Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Form 8.3 - Restore Plc

9 Aug 2021 10:59

Form 8.3 - Restore Plc

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:Investec Wealth & Investment
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Restore Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure6th August 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”Yes – Marlowe Plc 26th July 2021

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:  
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:3,217,3862.35%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:3,217,3862.35%  

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
Ordinary Shares Sale 707 505p

 

(b) Cash-settled derivative transactions

 

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

 

(ii) Exercise

 

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
N/A

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
N/A

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?NO

 

 

Date of disclosure:9th August 2021
Contact name:Phil Beardwell Chartered FCSI
Telephone number:020 7597 1356

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 

Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.